Seeing the brain differently
makes a world of difference

LEARN MORE ABOUT OUR APPROACH

News The latest from Sage

Press Releases

Sage Therapeutics and Biogen Announce SAGE-324 Phase 2 Placebo-Controlled KINETIC Study in Essential Tremor Met Primary Endpoint

Events

39th Annual J.P. Morgan Healthcare Conference

In the news

Investors: learn more about Sage’s pipeline and approach to developing treatments for brain health disorders

See All News

Patients & Care Partners Putting patients and their families first

We are rethinking care and how it is delivered to help patients and families impacted by brain health disorders.

Postpartum Depression

Major Depressive Disorder

Patient Advocacy Programs

See our resources for patients

Healthcare Providers It’s an exciting time in neuroscience

At Sage, our goal is to originate meaningfully differentiated drug candidates. We aim to discover new pathways to brain health by making medicines that matter so patients can get better, sooner.

Learn More About Our Approach

Clinical Trials A distinct approach to neuroscience drug development

Sage is committed to developing new medicines to treat life-altering brain health disorders.

Learn More About Our Ongoing Clinical Trials

Pipeline Advancing a Leading Brain Health Portfolio

We seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential brain health disorder treatments.

Learn More About Our Programs and Research

Careers Rethinking brain health disorders to make life better for patients and their families

Sage is a place where unconventional thinking to solve problems with new ideas is welcome - and where unconventional thinkers can imagine what's possible and do big.

Experience Our Culture